Previous 10 | Next 10 |
Comstock Holding Companies (CHCI) -15%.VerifyMe (VRME) -15% on stock offering.Neovasc (NVCN) -14% on stock offering; pared yesterday's gains on patent news.Enlivex Therapeutics (ENLV) -13% on stock offering.Salem Media Group (SALM) -13%.Limbach Holdings (LMB) ...
Stealth BioTherapeutics (MITO) inks agreements with institutional investors for the purchase and sale of ~2.4M ADSs, each representing 12 ordinary shares, at a purchase price of $2.00/ADS in a registered direct offering.Expected gross proceeds are ~$4.7M. Net proceeds will be used f...
Stealth BioTherapeutics Announces Pricing Of $4.7 Million Registered Direct Offering Of American Depositary Shares PR Newswire BOSTON , Feb. 10, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on th...
Stealth BioTherapeutics to Participate in Upcoming January Investor Conferences PR Newswire BOSTON , Jan. 7, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commerc...
TAT Technologies (TATT) +37% after signing strategic agreement with Honeywell.Change Healthcare Inc. (CHNG) +35% as UnitedHealth to acquire the company for $25.75 in cash.DBV Technologies S.A. (DBVT) +19%.Aurora Cannabis (ACB) +17% on possible Georgia 'blue sweep'.HEXO (HEXO) +17%...
Stealth BioTherapeutics (MITO) plans to meet with the FDA's Division of Cardiology and Nephrology ((DCN)) regarding its upcoming NDA submission for elamipretide for the treatment of cardiomyopathy in Barth syndrome.This Type B Pre-NDA meeting follows prior interactions during which the Agency...
Stealth BioTherapeutics Granted Pre-NDA Meeting For Elamipretide As A Treatment For Cardiomyopathy In Barth Syndrome Type B meeting scheduled with FDA Division of Cardiology and Nephrology Management to host conference call tomorrow at 8:30am ET PR Newswire BOS...
Biotech Penny Stocks To Watch With Recent Updates It’s funny to think that 2020 is almost over yet penny stocks remain a major focus for traders right now. One of the main reasons for this has been the unrelenting focus on volatility. Believe it or not, I think 2020 was p...
Looking For Biotech Penny Stocks Right Now? One of the most active sets of penny stocks in 2020 has been biotech stocks. Aside from the obvious push from COVID-19 vaccine candidates, companies are utilizing the increased attention to build upon novel treatment pipelines. Evidenced b...
Stealth BioTherapeutics Announces Elamipretide Clinical Data to be Presented at the 13th International Conference on Cachexia, Sarcopenia and Wasting Diseases BOSTON , Dec. 9, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotech...
News, Short Squeeze, Breakout and More Instantly...
Stealth BioTherapeutics Corp. Company Name:
MITO Stock Symbol:
NYSE Market:
Stealth BioTherapeutics Corp. Website:
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON , Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the ...
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire SBT-272 Phase 1 safety and tolerability data support further clinical development SBT-272 was neuroprotective...
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire BOSTON , Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused o...